Want to join the conversation?
Oliver Chen of Cowen & Co. asks about the status of inventory. $FOSL said the trends were fairly stable throughout the channel for 2Q16. So sell-in pretty much was consistent with sell-through. Inventories in the channel seem pretty healthy for the company right now.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?